We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 16 Dec 2020
Print article
Image: Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event (Photo courtesy of Roche)
Image: Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event (Photo courtesy of Roche)
Roche (Basel, Switzerland) showcased leading-edge technology at its virtual booth at 2020 AACC Annual Scientific Meeting with demonstrations of the company’s newest additions to the cobas family of analyzers.

At the AACC Virtual 2020 Annual Scientific Meeting & Clinical Lab Expo, Roche demonstrated its new cobas pro integrated solution that allows laboratories to experience a new improved level of simplicity while achieving mid to high volume clinical chemistry and immunochemistry testing needs. Visitors to Roche’s virtual booth at AACC 2020 were able to see firsthand the newest innovations, including reduced maintenance, cobas AutoCal, and long on-board reagent stability. The cobas pro integrated solution includes the cobas ISE analytical unit that measures the concentration of sodium (Na+), potassium (K+) and chloride (Cl-), the all-new cobas c 503 analytical unit for clinical chemistry, and cobas e 801 analytical unit for immunochemistry. The state-of-the-art cobas pro offers a range of advanced features that help optimize workflow, improve productivity, and enhance reliability and turnaround times to support patient care.

Roche also gave viewers a peek behind the curtain to the innovations offered by cobas pure integrated solutions, the newest member of the cobas family of systems that is designed to deliver excellence, while at the same time simplifying daily work. Built on the latest technology, cobas pure integrated solutions combines clinical chemistry, immunoassay and ISE1 diagnostic testing on a footprint of just two square meters to achieve low to mid volume testing needs.


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Rickettsia Conorii Assay
RICKETTSIA CONORII ELISA

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Microbiology

view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more

Pathology

view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.